118 related articles for article (PubMed ID: 2118015)
21. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
22. Hydroquinone and catechol interfere with T cell cycle entry and progression through the G1 phase.
McCue JM; Lazis S; John Cohen J; Modiano JF; Freed BM
Mol Immunol; 2003 Jun; 39(16):995-1001. PubMed ID: 12749906
[TBL] [Abstract][Full Text] [Related]
23. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.
Grabstein K; Dower S; Gillis S; Urdal D; Larsen A
J Immunol; 1986 Jun; 136(12):4503-8. PubMed ID: 3086434
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
25. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
26. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
[TBL] [Abstract][Full Text] [Related]
27. Antisense oligodeoxynucleotides for IL-2, c-myc and transferrin receptor synchronize mitogen-activated lymphocytes in the G1 phase.
Kato J; Kohgo Y; Kondo H; Sasaki K; Niitsu Y
Scand J Immunol; 1994 May; 39(5):499-504. PubMed ID: 8191225
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro.
Morikawa K; Oseko F; Morikawa S; Sawada M
Antimicrob Agents Chemother; 1993 Dec; 37(12):2684-7. PubMed ID: 7509146
[TBL] [Abstract][Full Text] [Related]
29. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
[TBL] [Abstract][Full Text] [Related]
30. Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes.
Haga Y; Tempero MA; Kay D; Zetterman RK
Dig Dis Sci; 1996 Jul; 41(7):1468-74. PubMed ID: 8689926
[TBL] [Abstract][Full Text] [Related]
31. A sodium channel opener inhibits stimulation of human peripheral blood mononuclear cells.
Pieri C; Recchioni R; Moroni F; Marcheselli F; Falasca M; Krasznai Z; Gáspár R; Mátyus L; Damjanovich S
Mol Immunol; 1992 Apr; 29(4):517-24. PubMed ID: 1565099
[TBL] [Abstract][Full Text] [Related]
32. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
[TBL] [Abstract][Full Text] [Related]
33. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.
Rigby WF; Denome S; Fanger MW
J Clin Invest; 1987 Jun; 79(6):1659-64. PubMed ID: 2884234
[TBL] [Abstract][Full Text] [Related]
34. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells.
Chien EJ; Chang CP; Lee WF; Su TH; Wu CH
J Cell Biochem; 2006 Sep; 99(1):292-304. PubMed ID: 16619256
[TBL] [Abstract][Full Text] [Related]
35. Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae.
Kuo YC; Weng SC; Chou CJ; Chang TT; Tsai WJ
Br J Pharmacol; 2003 Nov; 140(5):895-906. PubMed ID: 14504132
[TBL] [Abstract][Full Text] [Related]
36. Effects of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression, and T cell adherence toward endothelial cells.
Kawakami A; Eguchi K; Ueki Y; Migita K; Ida H; Nakao H; Kurata A; Fukuda T; Ishimaru T; Kurouji K
Arthritis Rheum; 1991 Mar; 34(3):296-303. PubMed ID: 1900689
[TBL] [Abstract][Full Text] [Related]
37. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation.
Bettens F; Kristensen F; Walker C; Schwuléra U; Bonnard GD; de Weck AL
J Immunol; 1984 Jan; 132(1):261-5. PubMed ID: 6606667
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
Arya SK; Wong-Staal F; Gallo RC
J Immunol; 1984 Jul; 133(1):273-6. PubMed ID: 6427338
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
Wang JX; Tang W; Shi LP; Wan J; Zhou R; Ni J; Fu YF; Yang YF; Li Y; Zuo JP
Br J Pharmacol; 2007 Mar; 150(5):652-61. PubMed ID: 17262016
[TBL] [Abstract][Full Text] [Related]
40. Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, Lobenzarit.
Hirohata S
Clin Exp Rheumatol; 1992; 10(4):357-63. PubMed ID: 1356678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
